Integrated Genetic and Epigenetic Analysis Identifies Haplotype-Specific Methylation in the FTO Type 2 Diabetes and Obesity Susceptibility Locus

Recent multi-dimensional approaches to the study of complex disease have revealed powerful insights into how genetic and epigenetic factors may underlie their aetiopathogenesis. We examined genotype-epigenotype interactions in the context of Type 2 Diabetes (T2D), focussing on known regions of genomic susceptibility. We assayed DNA methylation in 60 females, stratified according to disease susceptibility haplotype using previously identified association loci. CpG methylation was assessed using methylated DNA immunoprecipitation on a targeted array (MeDIP-chip) and absolute methylation values were estimated using a Bayesian algorithm (BATMAN). Absolute methylation levels were quantified across LD blocks, and we identified increased DNA methylation on the FTO obesity susceptibility haplotype, tagged by the rs8050136 risk allele A (p = 9.40×10−4, permutation p = 1.0×10−3). Further analysis across the 46 kb LD block using sliding windows localised the most significant difference to be within a 7.7 kb region (p = 1.13×10−7). Sequence level analysis, followed by pyrosequencing validation, revealed that the methylation difference was driven by the co-ordinated phase of CpG-creating SNPs across the risk haplotype. This 7.7 kb region of haplotype-specific methylation (HSM), encapsulates a Highly Conserved Non-Coding Element (HCNE) that has previously been validated as a long-range enhancer, supported by the histone H3K4me1 enhancer signature. This study demonstrates that integration of Genome-Wide Association (GWA) SNP and epigenomic DNA methylation data can identify potential novel genotype-epigenotype interactions within disease-associated loci, thus providing a novel route to aid unravelling common complex diseases.

[1]  Stephan Beck,et al.  Epigenetic variation and inheritance in mammals. , 2006, Current opinion in genetics & development.

[2]  Michael Rehli,et al.  Allele-specific DNA methylation in mouse strains is mainly determined by cis-acting sequences. , 2009, Genome research.

[3]  L. Groop,et al.  Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion , 2008, Diabetologia.

[4]  M. Carless,et al.  Genetic Variation at the FTO Locus Influences RBL2 Gene Expression , 2009, Diabetes.

[5]  K. Dewar,et al.  Targeted screening of cis-regulatory variation in human haplotypes. , 2008, Genome research.

[6]  Eric T. Wang,et al.  Alternative Isoform Regulation in Human Tissue Transcriptomes , 2008, Nature.

[7]  E. Richards.  Inherited epigenetic variation — revisiting soft inheritance , 2006, Nature Reviews Genetics.

[8]  B. Tycko,et al.  Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation , 2008, Nature Genetics.

[9]  F. Holsboer,et al.  Dynamic DNA methylation programs persistent adverse effects of early-life stress , 2009, Nature Neuroscience.

[10]  Wolfgang Wagner,et al.  Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. , 2010, Genome research.

[11]  R. Plomin,et al.  Allelic skewing of DNA methylation is widespread across the genome. , 2010, American journal of human genetics.

[12]  M. McCarthy,et al.  Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes , 2007, Science.

[13]  Roger D. Cox,et al.  A Mouse Model for the Metabolic Effects of the Human Fat Mass and Obesity Associated FTO Gene , 2009, PLoS genetics.

[14]  Terence Hwa,et al.  Distinct changes of genomic biases in nucleotide substitution at the time of Mammalian radiation. , 2003, Molecular biology and evolution.

[15]  S. O’Rahilly,et al.  Human genetics illuminates the paths to metabolic disease , 2009, Nature.

[16]  R. Redon,et al.  Relative Impact of Nucleotide and Copy Number Variation on Gene Expression Phenotypes , 2007, Science.

[17]  Peter H. Westfall,et al.  Testing Association of Statistically Inferred Haplotypes with Discrete and Continuous Traits in Samples of Unrelated Individuals , 2002, Human Heredity.

[18]  Christian Gieger,et al.  New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk , 2010, Nature Genetics.

[19]  Yoshiyuki Sakaki,et al.  A comprehensive analysis of allelic methylation status of CpG islands on human chromosome 21q. , 2004, Genome research.

[20]  Kent L Thornburg,et al.  Effect of in Utero and Early-life Conditions on Adult Health and Disease Epidemiol Ogic a Nd Clinic a L Observations , 2022 .

[21]  S. O’Rahilly,et al.  Prevalence of Loss-of-Function FTO Mutations in Lean and Obese Individuals , 2009, Diabetes.

[22]  Jens C. Brüning,et al.  Inactivation of the Fto gene protects from obesity , 2009, Nature.

[23]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[24]  E. Bresnick,et al.  Developmentally dynamic histone acetylation pattern of a tissue-specific chromatin domain. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Hein Putter,et al.  Persistent epigenetic differences associated with prenatal exposure to famine in humans , 2008, Proceedings of the National Academy of Sciences.

[26]  M. Vingron,et al.  Methylation and deamination of CpGs generate p53-binding sites on a genomic scale. , 2009, Trends in genetics : TIG.

[27]  James Strait,et al.  Genome-Wide Association Scan Shows Genetic Variants in the FTO Gene Are Associated with Obesity-Related Traits , 2007, PLoS genetics.

[28]  Loïc Ponger,et al.  CpG dinucleotides and the mutation rate of non-CpG DNA. , 2008, Genome research.

[29]  Masayuki Orimo,et al.  A crucial role for adipose tissue p53 in the regulation of insulin resistance , 2009, Nature Medicine.

[30]  M. Jarvelin,et al.  A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.

[31]  Christian Schmidl,et al.  Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity. , 2009, Genome research.

[32]  Mark I McCarthy,et al.  Type 2 diabetes: new genes, new understanding. , 2008, Trends in genetics : TIG.

[33]  Beverley Balkau,et al.  Variation in FTO contributes to childhood obesity and severe adult obesity , 2007, Nature Genetics.

[34]  Lior Pachter,et al.  Sequence Analysis , 2020, Definitions.

[35]  Amy Bernard,et al.  Wnt signaling is required at distinct stages of development for the induction of the posterior forebrain , 2003, Development.

[36]  Joshua M Akey,et al.  Where do we go from here? Constructing genomic maps of positive selection in humans: , 2009 .

[37]  R. Shoemaker,et al.  Allele-specific methylation is prevalent and is contributed by CpG-SNPs in the human genome. , 2010, Genome research.

[38]  S. Batzoglou,et al.  Distribution and intensity of constraint in mammalian genomic sequence. , 2005, Genome research.

[39]  A. Feinberg,et al.  Stochastic epigenetic variation as a driving force of development, evolutionary adaptation, and disease , 2010, Proceedings of the National Academy of Sciences.

[40]  M. Esteller.  Cancer epigenomics: DNA methylomes and histone-modification maps , 2007, Nature Reviews Genetics.

[41]  Ian M. Morison,et al.  The imprinted gene and parent-of-origin effect database now includes parental origin of de novo mutations , 2005, Nucleic Acids Res..

[42]  M. Lynch.  Rate, molecular spectrum, and consequences of human mutation , 2010, Proceedings of the National Academy of Sciences.

[43]  Jelle J. Goeman,et al.  A global test for groups of genes: testing association with a clinical outcome , 2004, Bioinform..

[44]  D. Clayton,et al.  The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes , 2009, Nature Genetics.

[45]  Fatima Al-Shahrour,et al.  Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. , 2010, Genome research.

[46]  H. Bandelt,et al.  Median-joining networks for inferring intraspecific phylogenies. , 1999, Molecular biology and evolution.

[47]  A. Visel,et al.  ChIP-seq accurately predicts tissue-specific activity of enhancers , 2009, Nature.

[48]  M. McCarthy,et al.  Genome-wide association studies: potential next steps on a genetic journey. , 2008, Human molecular genetics.

[49]  Pardis C Sabeti,et al.  Genome-wide detection and characterization of positive selection in human populations , 2007, Nature.

[50]  Jonathan Schug,et al.  Genome-wide analysis of histone modifications in human pancreatic islets. , 2010, Genome research.

[51]  A. Bird,et al.  DNA methylation landscapes: provocative insights from epigenomics , 2008, Nature Reviews Genetics.

[52]  J. Michaud,et al.  Laminar organization of the early developing anterior hypothalamus. , 2006, Developmental biology.

[53]  Philippe Froguel,et al.  Loss-of-function mutation in the dioxygenase-encoding FTO gene causes severe growth retardation and multiple malformations. , 2009, American journal of human genetics.

[54]  Philippe Froguel,et al.  Variation Within the Gene Encoding the Upstream Stimulatory Factor 1 Does Not Influence Susceptibility to Type 2 Diabetes in Samples From Populations With Replicated Evidence of Linkage to Chromosome 1q , 2006, Diabetes.

[55]  T. Hansen,et al.  Regulation and Function of FTO mRNA Expression in Human Skeletal Muscle and Subcutaneous Adipose Tissue , 2009, Diabetes.

[56]  Scott M. Williams,et al.  The Genetic Structure and History of Africans and African Americans , 2009, Science.

[57]  J. Gulcher,et al.  Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution , 2007, Nature Genetics.

[58]  Ji Eun Lee,et al.  Canonical Wnt signaling through Lef1 is required for hypothalamic neurogenesis , 2006, Development.

[59]  R. Jirtle,et al.  Environmental epigenomics and disease susceptibility , 2007, Nature Reviews Genetics.

[60]  Ross Ihaka,et al.  Gentleman R: R: A language for data analysis and graphics , 1996 .

[61]  Boris Lenhard,et al.  Long-range gene regulation links genomic type 2 diabetes and obesity risk regions to HHEX, SOX4, and IRX3 , 2009, Proceedings of the National Academy of Sciences.

[62]  Owen T McCann,et al.  Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. , 2010, Genome research.

[63]  Stephan Beck,et al.  From genome to epigenome. , 2005, Human molecular genetics.

[64]  B. Christensen,et al.  Aging and Environmental Exposures Alter Tissue-Specific DNA Methylation Dependent upon CpG Island Context , 2009, PLoS genetics.

[65]  A. Visel,et al.  Genomic Views of Distant-Acting Enhancers , 2009, Nature.

[66]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[67]  A. Ferguson-Smith,et al.  Mechanisms regulating imprinted genes in clusters. , 2007, Current opinion in cell biology.

[68]  R. Durbin,et al.  A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis , 2008, Nature Biotechnology.

[69]  G. Abecasis,et al.  A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants , 2007, Science.

[70]  C. Rhodes,et al.  Pancreatic β-cell growth and survival – a role in obesity-linked type 2 diabetes? , 2002 .

[71]  C. Rhodes,et al.  Pancreatic beta-cell growth and survival--a role in obesity-linked type 2 diabetes? , 2002, Trends in molecular medicine.

[72]  Leah Barrera,et al.  ChIP‐chip: Data, Model, and Analysis , 2007, Biometrics.

[73]  Albert Jeltsch,et al.  Non-imprinted allele-specific DNA methylation on human autosomes , 2009, Genome Biology.

[74]  Nathaniel D. Heintzman,et al.  Histone modifications at human enhancers reflect global cell-type-specific gene expression , 2009, Nature.

[75]  Lee E. Edsall,et al.  Human DNA methylomes at base resolution show widespread epigenomic differences , 2009, Nature.

[76]  P. Poulsen,et al.  Metabolic and genetic influence on glucose metabolism in type 2 diabetic subjects--experiences from relatives and twin studies. , 2003, Best practice & research. Clinical endocrinology & metabolism.

[77]  Anson,et al.  DIET , LIFESTYLE , AND THE RISK OF TYPE 2 DIABETES MELLITUS IN WOMEN , 2001 .

[78]  Struan F. A. Grant,et al.  Association Analysis of the FTO Gene with Obesity in Children of Caucasian and African Ancestry Reveals a Common Tagging SNP , 2008, PloS one.

[79]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[80]  J. Pritchard,et al.  A Map of Recent Positive Selection in the Human Genome , 2006, PLoS biology.